Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2007-3-12
pubmed:abstractText
The junctional adhesion molecule (JAM) family is a key molecule in a process called transendothelial migration or diapedesis. Here, we report implications of JAM-C in cancer metastasis. We first determined the mRNA expression of JAMs in 19 kinds of cancer cell lines. JAM-C was expressed in most of tumors having potent metastatic properties. Especially in murine K-1735 melanoma cell lines, the highly metastatic sublines (M2 and X21) strongly expressed JAM-C when compared with the poorly metastatic ones (C-10 and C23). Next, we investigated the role of JAM-C in cancer metastasis by using human JAM-C (hJAM-C) gene-transfected HT1080 fibrosarcoma cells. In comparison with mock-transfected HT1080 cells, these cells showed a significant increase in the adhesion to various extracellular substrates and the invasion across a Matrigel-coated membrane. The knockdown of hJAM-C using small interfering RNA resulted in the suppression of both the adhesion and the invasion of HT1080 cells, suggesting that endogenous hJAM-C might be involved in tumor metastasis. Finally, we studied the role of hJAM-C in an in vivo experimental metastatic model. The results showed that the overexpression of hJAM-C in HT1080 cells significantly decreased the life spans of the tumorbearing mice. In contrast, the knockdown of hJAM-C in HT1080 cells suppressed the weight gain of the lungs with metastatic colonies. We conclude that the expression of JAM-C promotes metastasis by enhancing both the adhesion of cancer cells to extracellular matrices and the subsequent invasion.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
16
pubmed:volume
282
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8276-83
pubmed:meshHeading
pubmed-meshheading:17227766-Animals, pubmed-meshheading:17227766-CHO Cells, pubmed-meshheading:17227766-Cell Adhesion, pubmed-meshheading:17227766-Cell Adhesion Molecules, pubmed-meshheading:17227766-Cell Line, Tumor, pubmed-meshheading:17227766-Collagen, pubmed-meshheading:17227766-Cricetinae, pubmed-meshheading:17227766-Cricetulus, pubmed-meshheading:17227766-Drug Combinations, pubmed-meshheading:17227766-Humans, pubmed-meshheading:17227766-Immunoglobulins, pubmed-meshheading:17227766-Laminin, pubmed-meshheading:17227766-Lung Neoplasms, pubmed-meshheading:17227766-Male, pubmed-meshheading:17227766-Membrane Proteins, pubmed-meshheading:17227766-Mice, pubmed-meshheading:17227766-Neoplasm Invasiveness, pubmed-meshheading:17227766-Neoplasm Metastasis, pubmed-meshheading:17227766-Prostatic Neoplasms, pubmed-meshheading:17227766-Proteoglycans
pubmed:year
2007
pubmed:articleTitle
Junctional adhesion molecule-C promotes metastatic potential of HT1080 human fibrosarcoma.
pubmed:affiliation
Department of Medical Biochemistry and Center of Excellence Program in the 21st Century, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
pubmed:publicationType
Journal Article